{"id":3958,"date":"2020-11-27T17:03:04","date_gmt":"2020-11-27T22:03:04","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/hematology\/?p=3958"},"modified":"2020-11-27T17:03:04","modified_gmt":"2020-11-27T22:03:04","slug":"umit-tapan-md-david-hughes-pharmd-bcop-jasmine-patel-pharmd-bcop-and-bhavesh-shah-rph-bcop-receive-grant-from-pfizer","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/hematology\/2020\/11\/27\/umit-tapan-md-david-hughes-pharmd-bcop-jasmine-patel-pharmd-bcop-and-bhavesh-shah-rph-bcop-receive-grant-from-pfizer\/","title":{"rendered":"Umit Tapan, MD, David Hughes, PharmD, BCOP, Jasmine Patel, PharmD, BCOP and Bhavesh Shah, RPh, BCOP Receive Grant From Pfizer"},"content":{"rendered":"<p>&nbsp;<br \/>\n<div id='gallery-1' class='gallery galleryid-3958 gallery-columns-4 gallery-size-responsive_gallery'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='\/hematology\/files\/2020\/07\/Tapan-Umit-184x184.jpg'><img width=\"184\" height=\"184\" src=\"\/hematology\/files\/2020\/07\/Tapan-Umit-184x184.jpg\" class=\"attachment-responsive_gallery size-responsive_gallery\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/www.bumc.bu.edu\/hematology\/files\/2020\/07\/Tapan-Umit-184x184.jpg 184w, https:\/\/www.bumc.bu.edu\/hematology\/files\/2020\/07\/Tapan-Umit-184x184-150x150.jpg 150w, https:\/\/www.bumc.bu.edu\/hematology\/files\/2020\/07\/Tapan-Umit-184x184-100x100.jpg 100w\" sizes=\"(max-width: 184px) 100vw, 184px\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='\/hematology\/files\/2020\/11\/david.jpg'><img width=\"191\" height=\"174\" src=\"\/hematology\/files\/2020\/11\/david.jpg\" class=\"attachment-responsive_gallery size-responsive_gallery\" alt=\"\" loading=\"lazy\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='\/hematology\/files\/2020\/11\/girl.jpg'><img width=\"216\" height=\"173\" src=\"\/hematology\/files\/2020\/11\/girl.jpg\" class=\"attachment-responsive_gallery size-responsive_gallery\" alt=\"\" loading=\"lazy\" \/><\/a>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<a href='\/hematology\/files\/2020\/11\/guy.jpg'><img width=\"182\" height=\"176\" src=\"\/hematology\/files\/2020\/11\/guy.jpg\" class=\"attachment-responsive_gallery size-responsive_gallery\" alt=\"\" loading=\"lazy\" \/><\/a>\n\t\t\t<\/div><\/figure>\n\t\t<\/div>\n<\/p>\n<p>Congratulations to Umit Tapan, MD, David Hughes, PharmD, BCOP, Jasmine Patel, PharmD, BCOP, and Bhavesh Shah, RPh, BCOP, who received a grant for $250,000 through Pfizer for \u201cImproving Biomarker Driven Precision Therapy in NSCLC: The Importance of an Integrated Multidisciplinary Approach\u201d last week. This was part of a competitive grant process through Pfizer that was awarded to only two centers across the United States. This initiative is comprised of an education series over the next two years, primarily focused on addressing racial and socioeconomic disparities that impede access to healthcare. It will focus on three key areas:<\/p>\n<ol>\n<li>Best practices for optimal biomarker testing in NSCLC and the need to understand barriers impeding testing<\/li>\n<li>Understanding new\/novel targeted therapies for NSCLC including clinical data to direct treatment decisions<\/li>\n<li>Management of treatment-related toxicities that limit clinical benefit and may negatively impact quality of life<\/li>\n<\/ol>\n<p>The unique aspects of BU\/BMC\u2019s patient population, multi-disciplinary thoracic oncology team (comprised of oncologists, molecular pathologists, interventional radiologists, pharmacists), and our embedded specialty pharmacy services will provide realistic approaches to optimal management for metastatic NSCLC.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Congratulations to Umit Tapan, MD, David Hughes, PharmD, BCOP, Jasmine Patel, PharmD, BCOP, and Bhavesh Shah, RPh, BCOP, who received a grant for $250,000 through Pfizer for \u201cImproving Biomarker Driven Precision Therapy in NSCLC: The Importance of an Integrated Multidisciplinary Approach\u201d last week. This was part of a competitive grant process through Pfizer that [&hellip;]<\/p>\n","protected":false},"author":6467,"featured_media":3140,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4124],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts\/3958"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/users\/6467"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/comments?post=3958"}],"version-history":[{"count":6,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts\/3958\/revisions"}],"predecessor-version":[{"id":3967,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/posts\/3958\/revisions\/3967"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/media\/3140"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/media?parent=3958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/categories?post=3958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/hematology\/wp-json\/wp\/v2\/tags?post=3958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}